FIELD: chemistry.
SUBSTANCE: invention relates to a method for synthesis of N-(5-[3-(thiophene-2-carbonyl)-pyrazole[1,5-a]pyrimidin-7-yl]-2-fluoro-phenyl}-N-methyl-acetamide in polymorphic modification B, in which (5-amino-1H-pyrazol-4-yl)-thiophen-2-yl-methanone reacts with N-[5-(3-dimethylamino-acryloyl)-2-fluoro-phenyl]-N-methyl-acetamide in a solvent selected from a group comprising acetic acid, propionic acid and methanoic acid at 50°C until boiling point of the mixture is reached. (C1-C4)-alcohol is then added to the obtained mixture at temperature of 40°C-80°C, after which the obtained mixture is kept for at least 30 minutes a temperature of 30°C- 55°C for initiating crystallisation. The crystalline product is then separated.
EFFECT: method of obtaining a compound in polymorphic modification B, which can be used in medicine in treating and preventing anxiety, epilepsy, sleep disorders and insomnia.
8 cl, 3 dwg, 1 tbl, 1 ex
Title |
Year |
Author |
Number |
POLYMORPHIC MODIFICATION IN N-{5-[3-(THIOPHENE-2-CARBONYL)-PYRAZOLO[1,5-a]PYRIMIDIN-7-YL]-2-FLUORO-PHENYL}-N-METHYL-ACETAMIDE (VERSIONS), CONTAINING IT PHARMACEUTICAL COMPOSITION (VERSIONS), MEDICATION, METHOD OF OBTAINING SAID POLYMORPHIC MODIFICATION (VERSIONS) AND METHOD OF TREATMENT AND/OR PREVENTION OF NERVOUS DISORDERS |
2007 |
- Anglada Luis
- Gul'Etta Antonio
- Palomer Al'Bert
|
RU2413729C2 |
N-(5-ACETYL-2-FLUOROPHENYL)-N-METHYLACETAMIDE, METHOD OF PRODUCING N-[5-(3-DIMETHYLAMINO-ACRYLOYL)-2-FLUOROPHENYL]-N-METHYLACETAMIDE AND METHOD OF PRODUCING N-{2-FLUORO-5-[3-THIOPHENE-2-CARBONYL-PYRAZOLO[1,5-a]PYRIMIDIN-7-YL]PHENYL}-N-METHYLACETAMIDE |
2010 |
- Markil'Jas Fransisko
- Sal'Jares Rosel' Khuan
|
RU2503655C2 |
HALOGENISED PYRAZOLO[1,5-a]PYRIMIDINES (VERSIONS), METHODS FOR PREPARING THEM, BASED PHARMACEUTICAL COMPOSITION, INTERMEDIATE COMPOUNDS AND METHOD FOR PREPARING THEM (VERSIONS) |
2006 |
- Anglada Luis
- Gul'Etta Antonio
- Palomer Al'Bert
|
RU2478101C2 |
AMORPHOUS FORM OF N-{2-FLUORINE-5-[3-(THIOPHEN-2-CARBONYL)-PIRAZOLO[1,5-a]-PYRIMIDIN-7-YL]-PHENYL)-N-METHYL-ACETAMIDE, METHOD FOR PREPARING IT, PHARMACEUTICAL COMPOSITION (VERSIONS) CONTAINING SAID AMORPHOUS FORM AND DRUG AND METHOD OF TREATING AND/OR PREVENTING NERVOUS DISORDERS |
2007 |
- Anglada Luis
- Gul'Etta Antonio
- Palomer Al'Bert
|
RU2450005C2 |
PYRAZOLO[1,5-a]PYRIMIDINE COMPOUNDS, PHARMACEUTICAL COMPOSITION SHOWING ABILITY TO INHIBIT GABA RECEPTORS, AND DRUG FOR TREATING AND PREVENTING DISORDERS ASSOCIATED WITH GABA RECEPTOR INHIBITION |
2007 |
- Anglada Luis
- Gul'Etta Antonio
- Palomer Al'Bert
|
RU2458063C2 |
HETEROCYCLIC INHIBITORS OF Hh-SYGNAL CASCADE, BASED ON THEM MEDICINAL COMPOSITIONS AND METHOD OF TREATING DISEASES INDUCED BY ABBARANT ACTIVITY OF Hh-SIGNAL SYSTEM |
2007 |
- Ivashchenko Andrej Aleksandrovich
- Lavrovskij Jan Vadimovich
- Lakner Fred
- Maljarchuk Sergej Viktorovich
- Okun' Il'Ja Matusovich
- Savchuk Nikolaj Filippovich
- Tkachenko Sergej Evgen'Evich
- Khvat Aleksandr Viktorovich
|
RU2364597C1 |
CIS-2,4,5-TRIARYLIMIDAZOLINES |
2004 |
- Khejli Gregori Dzhej
- Kon Norman
- Lju Ehmili Ajtsun'
- Simonsen Klaus B.
- Vu Binkh Tkhankh
- Uehbber Stiven Ehvan
|
RU2319696C2 |
2-PHENYLAMINOPYRIMIDINE DERIVATIVES AS LEUCINE-RICH REPEAT KINASE 2 (LRRK2) MODULATORS FOR TREATMENT OF PARKINSON'S DISEASE |
2012 |
- Bejker-Glenn Charlz
- Berdik Daniel Dzhon
- Chembers Mark
- Chan Brajan K.
- Chen Khuejfen
- Estrada Entoni
- Ganzner-Toste Dzhanet
- Shor Daniel
- Svini Zakari
- Van Shumej
- Chzhao Gujlin
|
RU2661197C2 |
NOVEL PYRIMIDINE DERIVATIVE AND COMPOSITION CONTAINING SAME FOR PREVENTING OR TREATING NEURODEGENERATIVE DISEASES AND CANCER |
2021 |
- Li, Ge Kheon
- So, Dzhi En
- Yu, Dzhon Khon
- E, In Khe
- Sin, Kho Chkhul
- So, Chi Khi
- Kim, Son Khvan
- Son, Chin Sok
- Sim, Son Kheon
- Chkhe, Chon Khak
- Kan, Khi En
- Li, Chi Khun
- Khvan, Kon Kha
|
RU2825827C1 |
1,3-DISUBSTITUTED 4-METHYL-1H-PYRROL-2-CARBOXAMIDES AND USE THEREOF FOR PREPARING DRUGS |
2007 |
- Oberbersh Shtefan
- Zundermann Bernd
- Zundermann Korinna
- Bejsterveld Ehdvard
- Khennis Khagen-Genrikh
|
RU2463294C2 |